Autori: Budincevic Hrvoje
| Naslov | Fenebrutinib maintains low disease activity in relapsing multiple sclerosis: results from the FENopta trial open-label extension (Meeting Abstract) |
| Autori | Bar-Or Amit Oh Jiwon Dufek Michal Budincevic Hrvoje Habek Mario Caunt Maresa Thomas Piia Sierzega Malgorzata Clayton David Cheng Ying Fang Ratchford John Goodyear Alexandra Drulovic Jelena S 
|
| Info | MULTIPLE SCLEROSIS JOURNAL, (2024), vol. 30 br. 3, Suppl. S, str. 1021-1022 |
| Ispravka | Web of Science Elečas Rang časopisa |
     |
| Naslov | Cerebrospinal fluid and MRI analyses of fenebrutinib treatment in multiple sclerosis reveal brain penetration and early reduction of new lesion activity: results from the phase II FENopta study (Meeting Abstract) |
| Autori | Bar-Or Amit Dufek Michal Budincevic Hrvoje Drulovic Jelena S Habek Mario Hua Le Weber Martin Thomas Piia Napieralski Julie Clayton David Kuruvilla Denison Qi Qi Xu Yan Goodyear Alexandra Oh Jiwon
|
| Info | MULTIPLE SCLEROSIS JOURNAL, (2023), vol. 29 br. , Suppl. 3, str. 1049-1050 |
| Projekat | F. Hoffmann-La Roche Ltd |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | Efficacy and Safety of Fenebrutinib, a Noncovalent, Reversible BTK inhibitor, in MS: Primary Results of a Phase 2 Trial (Meeting Abstract) |
| Autori | Hua Le Bar-Or Amit Weber Martin Habek Mario Budincevic Hrvoje Thomas Piia Napieralski Julie Ratchford John Qi Qi Sierzega M Drulovic Jelena S
|
| Info | EUROPEAN JOURNAL OF NEUROLOGY, (2023), vol. 30 br. , Suppl. 1, str. - |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | The cost of ischaemic stroke in Croatia (Article) |
| Autori | Benkovic Vanesa Parker Mark Novakovic Tanja Mestrovic Andrija Budincevic Hrvoje |
| Info | EUROPEAN STROKE JOURNAL, (2023), vol. 8 br. 1_SUPPL, str. 21-27 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
|
